Literature DB >> 19028512

Structural characteristics of anabolic androgenic steroids contributing to binding to the androgen receptor and to their anabolic and androgenic activities. Applied modifications in the steroidal structure.

A G Fragkaki1, Y S Angelis, M Koupparis, A Tsantili-Kakoulidou, G Kokotos, C Georgakopoulos.   

Abstract

Anabolic androgenic steroids (AAS) are synthetic derivatives of testosterone introduced for therapeutic purposes providing enhanced anabolic potency with reduced androgenic effects. Androgens mediate their action through their binding to the androgen receptor (AR) which is mainly expressed in androgen target tissues, such as the prostate, skeletal muscle, liver and central nervous system. This paper reviews some of the wide spectrum of testosterone and synthetic AAS structure modifications related to the intended enhancement in anabolic activity. The structural features of steroids necessary for effective binding to the AR and those which contribute to the stipulation of the androgenic and anabolic activities are also presented.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19028512     DOI: 10.1016/j.steroids.2008.10.016

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  20 in total

1.  Computational Assessment of Pharmacokinetics and Biological Effects of Some Anabolic and Androgen Steroids.

Authors:  Marin Roman; Diana Larisa Roman; Vasile Ostafe; Alecu Ciorsac; Adriana Isvoran
Journal:  Pharm Res       Date:  2018-02-05       Impact factor: 4.200

Review 2.  Anabolic androgenic steroid abuse: multiple mechanisms of regulation of GABAergic synapses in neuroendocrine control regions of the rodent forebrain.

Authors:  J G Oberlander; D M Porter; C A A Penatti; L P Henderson
Journal:  J Neuroendocrinol       Date:  2012-01       Impact factor: 3.627

3.  Insights and prospects for ion mobility-mass spectrometry in clinical chemistry.

Authors:  David C Koomen; Jody C May; John A McLean
Journal:  Expert Rev Proteomics       Date:  2022-01-17       Impact factor: 3.940

4.  Effects of sex hormones on inflammatory response in male and female vascular endothelial cells.

Authors:  Giosuè Annibalini; Deborah Agostini; Cinzia Calcabrini; Chiara Martinelli; Evelin Colombo; Michele Guescini; Pasquale Tibollo; Vilberto Stocchi; Piero Sestili
Journal:  J Endocrinol Invest       Date:  2014-06-20       Impact factor: 4.256

Review 5.  The Buzz about anabolic androgenic steroids: electrophysiological effects in excitable tissues.

Authors:  Joseph G Oberlander; Carlos A A Penatti; Donna M Porter; Leslie P Henderson
Journal:  Neuroendocrinology       Date:  2012-09-14       Impact factor: 4.914

Review 6.  Neurotoxicity by synthetic androgen steroids: oxidative stress, apoptosis, and neuropathology: A review.

Authors:  Cristoforo Pomara; Margherita Neri; Stefania Bello; Carmela Fiore; Irene Riezzo; Emanuela Turillazzi
Journal:  Curr Neuropharmacol       Date:  2015-01       Impact factor: 7.363

Review 7.  Anabolic Androgenic Steroid (AAS) related deaths: autoptic, histopathological and toxicological findings.

Authors:  Paola Frati; Francesco P Busardò; Luigi Cipolloni; Enrico De Dominicis; Vittorio Fineschi
Journal:  Curr Neuropharmacol       Date:  2015-01       Impact factor: 7.363

8.  Histological changes in testes of rats treated with testosterone, nandrolone, and stanozolol.

Authors:  Siti Syairah Mohd Mutalip; Gurmeet Kaur Surindar Singh; Aishah Mohd Shah; Mashani Mohamad; Vasudevan Mani; Siti Nooraishah Hussin
Journal:  Iran J Reprod Med       Date:  2013-08

9.  Pharmaceutical drugs supporting regeneration of small-intestinal mucosa severely damaged by ionizing radiation in mice.

Authors:  Hiroshi Ishihara; Izumi Tanaka; Haruko Yakumaru; Mika Tanaka; Kazuko Yokochi; Makoto Akashi
Journal:  J Radiat Res       Date:  2013-05-31       Impact factor: 2.724

10.  Selective steroid oxyfunctionalisation by CYP154C5, a bacterial cytochrome P450.

Authors:  Paula Bracco; Dick B Janssen; Anett Schallmey
Journal:  Microb Cell Fact       Date:  2013-10-17       Impact factor: 5.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.